Unexplained weight loss (UWL), defined as a loss of 5% or more of total body weight within a six to twelve month period without a clear etiology, often presents a diagnostic challenge for clinicians. This article aims to provide a comprehensive approach to diagnosing UWL, focusing on the importance of a thorough patient history, physical examination, and appropriate laboratory testing.
The first step in diagnosing UWL is a thorough patient history. Inquiring about changes in appetite, dietary habits, and physical activity levels can often provide clues to the underlying cause. Additionally, a detailed review of systems can reveal symptoms that suggest specific organ system involvement. Psychosocial history, including stressors and mood changes, can also be crucial, as depression can often manifest as UWL.
A comprehensive physical examination is also essential. The presence of lymphadenopathy, hepatosplenomegaly, or abnormal thyroid findings may suggest malignancy, infection, or endocrine disorders, respectively. Skin changes can indicate malabsorption or chronic liver disease, while neurological findings may point towards a neurodegenerative disorder.
Appropriate laboratory testing is the next step, guided by clues from the history and physical examination. Basic tests should include a complete blood count, metabolic panel, thyroid function tests, and urinalysis. Depending on the clinical suspicion, further tests may include imaging studies, endoscopy, or biopsy.
UWL is a complex clinical presentation that requires a methodical and comprehensive diagnostic approach. A detailed patient history, thorough physical examination, and appropriate laboratory testing are key to identifying the underlying cause. Further research is needed to develop more precise diagnostic algorithms and to understand the pathophysiology of UWL in patients with no identifiable cause.
1.
Imetelstat for MDS-relateret anemia er godkendt af Food and Drug Administrations panel.
2.
Navigating breast cancer diagnosis, treatment, and survivorship in Ethiopia
3.
No Gestational Diabetes-Cancer Link; Cholesterol and Cancer; Oncologist Saves Umpire
4.
Specialized imaging improves overall prostate cancer survival by identifying benefits of salvage radiotherapy
5.
Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma
1.
Ferroptosis as a Therapeutic Target in Cancer
2.
Subchorionic Hematoma: Causes, Symptoms, and Treatment
3.
Adaptive Cell Therapies for Solid Tumors
4.
Engineered Niches for Blood-Cell Regeneration: Current Concepts and Clinical Implications
5.
Unlocking the Potential of Hemin: A Novel Approach to Health and Wellbeing
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
2.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
3.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III
4.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
5.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation